chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Woke up in the middle of the night with pain in head, neck, and shoulders with dizziness and weakness  per patient: "felt like i was deep underwater and head going to explode".
Patient received lower-than-authorized dose of Pfizer COVID-19 vaccine; patient will receive the >/= 12yrs Pfizer formulation at the appropriate interval for 2nd dose to complete the primary series.  No adverse events noted.
Slow build of symptoms from June-November. Wheezing, phlegm, cough that got progressively worse over time.   Treatment: steroidal inhaler, prednisone pills, steroidal shot, Trelegy inhaler. Symptoms were gone after a couple of days.
large red blotch over injection site, swelling at vaccine site, joint pain and stiffness all lasting for >2 days post vaccination
Information has been received from a physician concerning a patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient came down with chicken pox. Medical attention was sought. The patient's outcome was not known. No product quality complaint was involved. Additional information has been requested.
I got red dots and bumps all over both feet, legs, arms, and hands. I believe it was petechiae
The patient was given Novavax as a booster dose, but had previously received one monovalent mRNA vaccine booster. The patient was monitored after the vaccine was given for 15 minutes with no adverse events.  The patient was called the next day and reported symptoms after vaccination including soreness at the site and muscle and bone pain that lasted through the night, but symptoms had improved greatly by 1:30 pm at the time of the call. No other outcomes reported. Patient was made aware of the immunization guidelines.
Breakthrough case admission after 4 vaccines Pfizer 1/8/21 Lot# EL3249;  Pfizer 2/8/21 Lot# EM9810;  Pfizer 10/16/21 Lot# 301558A;  Pfizer 5/5/22 Lot# FJ9943
She feels sick ;if she is positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 13Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset Apr2021, outcome "unknown", described as "She feels sick ;if she is positive".  Additional information: She got her 1st dose last April 13Apr2021. And today she stated she feels sick and now she wants to ask if she will be or she should be tested if she is positive, She is just asking if she needs to be tested because she feels sick today.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Redness and slight swelling at the injection site. Slightly warm to the touch. Her symptoms have decreased from yesterday.
High fever 102+ 3 days, swelling 6 days, redness 6 days, aching in entire arm.
Hiccups   every 2 hours for 5 hours long. Eyes and Face swollen after 2 hours vaccine was given.  cramps and fever.
Site: Swelling at Injection Site-Mild, Additional Details: Patient developed a small nodule at injection site. Patient reported no pain, itch, or irritation besides the hard nodule. no limit in mobility. patient was given an ice pack an observed for 20 minutes. Patient reported he was feeling well before leaving the pharmacy. Will follow up with the patient
Around April 14, 2022 I was having a sore throat, and I had a tickle in my throat. I was coughing. I was feeling a little fatigued. That lasted for a few days. Then I felt like I was getting better. Then I started feeling more congested and having to blow my nose for a few days. Around April 25, 2022 my throat got more sore than what it was before. I looked in the back of my throat and I could see it was red with white dots. It was hard to swallow. I made an appointment with my doctor. I saw her on April 27, 2022 and she took a test. She looked at my ears, nose, and throat. She said I had some eustachian tube dysfunction in my ears but more so in the left ear. I was feeling overall congested. The doctor said to do sinus rinses and then take Flonase after twice a day morning and night. I did it once a day for about 4 or 5 days. I was eating popsicles and stayed hydrated. Then I was feeling pretty much better. Over the past last week I was having a lingering cough. One night it woke me up. Around April 17, 2022 I had lost my sense of smell and taste. I started regaining it right before I saw the doctor so that lasted a little over a week, and then it came back slowly. I can smell and taste everything that I used to now. The doctor also said that I could take some ibuprofen 600mg. Before I knew I had covid I was taking some Sudafed, cold medicine, lots of cough drops, and throat spray. In December I started taking sertraline, trazadone, and hydroxyzine. I took some fertility medication in January 2022 and February 2022 by getting an IUI treatment.
11/7/11  Pain at injection site L arm. 11/8/11 Difficulty moving L arm, pain in L axilla.  Resolved 11/9/11.   11/15/11  Pain L arm, headache persisted x 1 week. 11/18/11  Neck, l arm, back pain 10/10 on pain scale.   11/19/11  Seen by urgent care center given Skelaxin recommended MRI.  Gradually improving. Pt spoke with family physician.  Out of town x 2 weeks.  Did not want to do MRI since she was feeling better.  Will follow up in 2 weeks.
Almost 6 weeks in ICU with paralysis, respiritory arrest, death from Guillain Barre Syndrome
Patient did not have an adverse reaction to the vaccine.  The patient had received a Janssen vaccine and a Moderna vaccine in 2021.  A monovalent was in error when a Bivalent should have been given.
Administered after sitting at room temperature for 16-18 hours; Administered after sitting at room temperature for 16-18 hours; Sore arm; pain round rib cage and chest area; pain round rib cage and chest area; This is a spontaneous report from a contactable pharmacist (patient's husband).  A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 18Jul2021 (age at vaccination was 43 years old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included dose 1 (Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as DOSE 1, SINGLE. The reporter pharmacist said he took home the Pfizer-BioNTech Covid-19 Vaccine and administered the 2nd dose to his 43-year-old wife. However, he said prior to that, it was sitting at room temperature at around 1:00 for 16-18 hours. He wants to know if this is considered a temperature excursion. When asked what specific temperature the vaccine was exposed to, HCP said he does not know. He said it was a diluted vaccine stored inside a vial. HCP also said that after receiving the 2nd dose, his wife experienced sore arm, and pain around her ribcage and chest area. He wants to know what are the side effects she should be expecting. At the time of this report, the outcome of all the events was unknown.  Information about lot/batch number has been requested.
Large lump under right armpit; Water retention on torso, down to stomach on right/SHOT SIDE ONLY; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 25Mar2021 at 12:15 (at the age of 43-years-old) as a single dose for Covid-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food, or other products (as far as patient was aware of). The patient did not receive any concomitant medications within 2 weeks of the vaccine.  Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Mar2021, the patient experienced large lump under right armpit and significant water retention on torso, down to stomach on right and never experienced this before. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received treatment for the reported events. The clinical outcome of axillary lump and water retention was not recovered at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report was received from a pharmacist concerning to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 16-JUL-2014, the patient was vaccinated with the second dose of ZOSTAVAX (dose, strength, lot number, expiration date and route were not reported), subcutaneous. Co-suspect and concomitant therapies were not reported. The pharmacist reported that a patient received ZOSTAVAX on an unspecified date in September 2013. The pharmacist reported that the patient inadvertently received a second dose of ZOSTAVAX today, on 16-JUL-2014. No adverse effects reported. Additional information has been requested.
This spontaneous report as received from a physician refers to multiple unspecified patients. On an unknown date multiple unspecified patients were vaccinated with ROTATEQ (strength, dose, route unknown) that was stored improperly. No adverse effects reported. The outcome of the event was unknown. Additional information has been requested.
age 80 Admit 1/27/2023 with Afib with RVR as principal problem. COVID positive 1/27/2023. Noted Acute respiratory failure with hypoxia on discharge diagnoses. Patient was made comfort care. Date of death: 2/1/2023
This case was reported by a other health professional and described the occurrence of vaccine underdose in a 28-year-old patient who received ENGERIX B pediatric (batch number BT24B, expiry date unknown). On 31st October 2014, the patient received ENGERIX B pediatric .5 ml. On an unknown date, an unknown time after receiving ENGERIX B pediatric, the patient experienced vaccine underdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the vaccine underdose and inappropriate age at vaccine administration were unknown. Additional information received: Pediatric dose given to an adult. No adverse event reported.
Reports that child experienced redness and moderate pain the day of the immunization as well as the next day in both the right and left legs.   No fever reported
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A 37 year-old male patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Lot number: EW0172) as dose 1, single and administration date 03May2021 (Lot number: EW0183) as dose 2, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 2021, outcome "not recovered", described as "Tinnitus-ringing in ears". Additional information: Reporter reported that 37 year old son has expressed to me the same symptoms, tinnitus. He had continued to experience the same side effects to date as well. He had 2 shots. His lot numbers for the two shots and dates Were lot EW0172 03May2021 Lot EW0183 01Apr2021. No follow-up attempts are possible. No further information is expected.
fatigue; high temperature; Chiils; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced FATIGUE (fatigue), PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, FATIGUE (fatigue) had not resolved and PYREXIA (high temperature), CHILLS (Chiils) and HEADACHE (headache) was resolving.            No relevant concomitant medications were reported.
This case was reported by a healthcare professional (also the consumer) and described the occurrence of chest rash in a 42-year-old female subject who was vaccinated with FLULAVAL. Concurrent medications included TOPAMAX, Propranolol, PROTONIX and LIPITOR. On the morning of 2 October 2008 the subject received a dose of FLULAVAL at 0.5 ml in the right arm. Later that evening, th subject developed a rash on chest that spread to the rest of her body. The reporter/nurse stated that the rash worsened over the first three days and was unresolved at the time of reporting. The healthcare professional considered the events were possibly related to vaccination with FLULAVAL.
This case was reported by a pharmacist via call center representative and described the occurrence of urticarial rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 4 days after receiving SHINGRIX, the patient experienced urticarial rash. On an unknown date, the outcome of the urticarial rash was unknown. It was unknown if the reporter considered the urticarial rash to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. After vaccination, the patient experienced rash from head to toe. The pharmacist also reported that, it was hives not just a rash. The pharmacist wanted to know, should the patient get the second shot of SHINGRIX.
Moderna 2/9/21 and 3/11/21. Positive on 1/17/22
Patient was given an immunization that expired the previous month . Patient did not experience any symptoms during or after administration of vaccine.
Large red hot painful swollen site, large oval on upper left arm and shoulder. Swollen armpit and neck glands on same side.
Arm was sore; Urine was dark, almost a brown color; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 87-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th April 2022, the patient received the 2nd dose of Shingrix. On 27th April 2022, 1 days after receiving Shingrix, the patient experienced pain in arm and dark urine. On an unknown date, the outcome of the pain in arm and dark urine were unknown.   It was unknown if the reporter considered the pain in arm and dark urine to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-Apr-2022 Reporter's Comments: The patient received shingrix and noticed that, the patient's urine was dark as well as arm was sore on reporting day. On vaccination day, the patient had drug test which showed urine was fine. The consent to follow up was provided.
I had shortness of breath, very tired, I had been exposed to someone who had COVID-19. I decided to use my home COVID-19 test that came back positive. Once it came back positive I went to the hospital and they did a chest x-ray that came back clear. They did prescribe me a cough suppressant, MUCINEX, albuterol and PAXLOVID. I started to the medications immediately. I am still feeling tired, I have chest pains when I cough and shortness of breath when I walk around.
Itchy hives across body. Started on elbow of left arm (same as vaccination arm) and down arm to hand. Overnight, appeared around torso, both legs, and opposite arm.
Onset of red papular/fine vesicular rash on torso 8-10 days after receiving vaccines noted below. Subsequently developed itching and then numbness and pain in the torso from mid chest to lower abdomen. Also has some instability of gait (ataxia) with mild lower extremity weakness. Treated with Acyclovir, Gabapentin, narcotic analgesics and amitriptyline. Still has slight rash and moderate pain as of 1/24/2008.
Pt developed dyspnea on exertion and atypical chest pain following dose #1, lasting approx. 15 days-- seemed to be improving on its own by the time she got dose #2
About 6 days after receiving flu shot, PT developed body aches, sore throat, low grade temp. Details unknown. This pt had flu vaccine in an area where they live. Information of vaccine are unavailable. Possible reaction/viral illness. Treated in MD office 11/21/2002
No erythema or tenderness at site. 3/24/15 Vaccine Tdap administered. 3/27/15 Vomiting immediate care. 3/29/15 Acute bronchospasm immediate care prednisone, albuterol. 3/31/15 ZPAK given for cough, SOB, patchy opacity left lunch back. ER to R/O clot. 4/5/15 ER R/O clot.
Initial case report received from a nurse, via Novartis Medical Communication on 30 OCT 2009. A 59 year-old female patient was vaccinated with 0.5 ml of FLUVIRIN (batch no. 97848P1A) i.m., on 28 OCT 2009. On the same day, the patient experienced metallic taste in mouth. At the time of this report, the outcome of the event was reported as not recovered. MedCom reference no.: NA09-007253. This case was earlier reported as MA2009-3784. Follow up report received from nurse on 05 Mar 2010: The patient received FLUVIRIN (batch no. 98748P1A). After 2 hours of vaccination patient took 2 OTC ALEVE. The patient experienced strong metallic taste in mouth after 2 hours of taking of ALEVE (i.e. after 4 hours of vaccination). The patient also took breakfast, coffee with cream and sugar prior to vaccination. The patient reported that the metallic taste lasted for 2-3 days. The causality of the event was not reported.
This spontaneous report as received from a registered pharmacist refers to a now 88 year old female patient. The patient was vaccinated with a dose of PNEUMOVAX23 on approximately 31-JUL-2011 (reported as "1 year ago") (lot# not reported). On an unknown date the patient experienced swelling and edema at the injection site. It was unknown if the patient sought medical attention. The outcome of swelling and edema at the injection site was reported as recovered. Additional information has been requested.
No events immediately following injection.  Six days later I started to experience an allergic reaction for some unknown reason with red welts over body, swelling. and itching.  On the 7th day, my tongue and throat started swelling and I went to Urgent Care.   I was treated with prednisone and epinephrine on 4/18/21 and released.  Prescription given for 5 days of prednisone.  No further symptoms after 4/18/21.  Physician recommended I file a report with VAERS.
Sore arm with first dose; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318), via intramuscular on left arm on 24Jan2021 at 18:30 at single dose for COVID-19 immunization. The relevant medical history included diagnosed allergies, compromised immune status, respiratory illness, genetic /chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity: autoimmune disease, PBC (Primary biliary cholangitis) (PBC is her autoimmune condition and was diagnosed 10 years ago). Concomitant medications were reported as none. The patient had sore arm with first dose on 24Jan2021. The outcome of the event was recovering.
Patient presented to pharmacy on 10/10/20 with a large sore on her right arm that had a scab that was removed and a red circle around the area that looked previously scabbed over.  Patient stated that she thought it was from her flu shot that she received on 9/16/20.  She couldn't give any details about when the symptoms started or how long they had been going on for.  Patient was advised to seek treatment.  She was then prescribed an antibiotic [cephalexin 500mg 1 capsule 4 times daily for 10 days]
In the beginning a very strong pain arms whole body after the stomach started the back and everything got worse for 4 days going to and from the emergency room and then still hospitalized all due to problems after the vaccine in the last exam the variant was positive for guillen barrer before discovering this he lost his sight for two hours he cannot walk he lost the strength of his limbs and his pressure shot up he has dysphacia and is still hospitalized with physical therapy
arm hurt; on the injection site which was hot; dramatic red circle, pretty big about 10 inches by 8 inches, erythema 10 x 8 cm in size; on the injection site which was painful; A spontaneous report was received from a health care professional regarding a 60 year old male patient who experienced red circle around injection site and erythrema after the 12th day of administion of vaccine. The patients medical history is not provided. Concomittant product usage was not provided.  The patient received 1st dose of mRNA-1273 on 23 Jan 2021  in the right arm , Batch Number 012L20A for prophylaxis of covid 19 infection. Treatment information was not provided. She gave her consent for follow up. Lab parameters and no other reactions are reported. Action taken with mRNA-1273 in response to the event was not provided. She wants to know whether she can take the second dose.
It was reported that a 44 year old female patient received a Fluzone SV vaccination. Reportedly sometime after receiving the vaccination the patient developed 3cm of cellulitis, urticaria and a sore throat. Further information is requested. From additional correspondence received on 02/21/2001, it was reported, "reviewed, no additional information at this time - CD 02/14/2001". This case is closed.
Had severe sore throat in middle of night on 4/14/23; coughing; no temperature
was supposed to be administered another vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 6-month-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA677A, expiry date 30-APR-2023) for prophylaxis.   On 10-APR-2023, the patient received the 1st dose of Menveo. On 10-APR-2023, an unknown time after receiving Menveo, the patient experienced wrong vaccine administered (Verbatim: was supposed to be administered another vaccine). The outcome of the wrong vaccine administered was unknown.   Additional Information: GSK Receipt date: 10-APR-2023 Nurse reported that Menveo was administered to the patient unintentionally.  HCP (Health care professional) was asking about the recommended age and was unaware the patient fall within recommended age.  Patient had not received any meningococcal vaccines before and was supposed to be administered another vaccine, did not report which one. The reported consented to follow-up via email. Patient had not received any meningococcal vaccines before and was supposed to be administered another vaccine which led to wrong vaccine administered.
Information has been received from a physician concerning a 14 year old female patient with hypertension who on 11-FEB-2008, was vaccinated with a first 0.5ml dose of Gardasil. On 16-FEB-2008, the patient experienced a seizure- x link hypohydrotic ectodermal dysplasia. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.